It doesn't. It is just another carrot to us bag holder shareholders. It will only mean something if FDA grants approval to start clinical trials. It has been two years and nothing to show for it except for empty promises.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.